Breaking News
5371 - 5385 of 6609 results
Prev
357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441
Next
August 28, 2007
Pfizer has licensed non-exclusive, worldwide rights to Xoma Ltd.'s bacterial cell expression (BCE) technology for phage display and other research, development and manufacturing of antibody products.
Under the terms of the agreement, Xoma will r…
Read More »
August 28, 2007
Schering-Plough/Merck Pharmaceuticals' (SPM) NDA for loratadine/montelukast has been accepted by the FDA for review. The drug is a single tablet that contains the active ingredients of Claritin (loratadine) and Singulair (montelukast sodium), both of…
Read More »
August 27, 2007
NovaQuest, the strategic partnering group of Quintiles Transnational, has made a strategic investment in Topigen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specializing in respiratory disorders. The investment, part of a…
Read More »
August 27, 2007
Hani S. Zaki has been appointed vice president and general manager of Periapproval Services for Covance, Inc. Mr. Zaki will be responsible for managing large research studies on the use of pharmaceuticals in real world clinical practice.
Pri…
Read More »
August 27, 2007
Pfizer and Bristol-Myers Squibb have finalized their collaboration agreement to research, develop and commercialize DGAT-1 inhibitors. Pfizer's DGAT- 1 discovery program includes advanced preclinical compounds with potential applications for the trea…
Read More »
August 24, 2007
Gene Logic, Inc. has entered into a drug repositioning and development agreement with Merck Serono to seek alternative development paths for several Merck Serono drug candidates that were discontinued or de-prioritized in clinical trials for reasons…
Read More »
August 24, 2007
MedImmune has opened a new, state-of-the-art pilot lab facility at its Gaithersburg site headquarters. The facility features the latest equipment and process automation systems and will support the company's clinical product pipeline with additional…
Read More »
August 24, 2007
Bengt Danielsson, M.D., Ph.D., has been appointed vice president, PharmaNet Consulting. He joins the company from the Swedish Medical Product Agency where he served as scientific director/professor in pharmacology and toxicology for the past three ye…
Read More »
August 23, 2007
Pro-Pharmaceuticals, Inc. has retained Camargo Pharmaceutical Services to provide strategic regulatory support for the company’s 505(b)(2) submissions for Davanat with the FDA. Camargo’s regulatory support includes the preparation and sub…
Read More »
August 23, 2007
Cephalon, Inc. has signed an agreement to acquire the North American rights to Amrix (cyclobenzaprine hydrochloride extended-release capsules) from ECR Pharmaceuticals for $100 million cash. ECR is eligible to receive future cash payments based on th…
Read More »
August 23, 2007
GPC Biotech AG is restructuring and will reduce its U.S. staff by 46 employees (approximately 15%) with reductions in the commercialization, drug development and general and administrative groups. The company also announced that Martine George, M.D.…
Read More »
August 22, 2007
Frank A. D'Amelio has been named senior vice president and chief financial officer of Pfizer, effective in mid-September. Mr. D'Amelio is a senior executive with almost three decades of operating and financial experience at AT&T, Lucent Technolog…
Read More »
August 22, 2007
Pfizer broke ground on a $50 million expansion at its Chesterfield campus that reflects the company's increased investment in biopharmaceuticals. The expansion doubles the size of a pilot plant that produces protein-based, injectable biologic drugs f…
Read More »
August 22, 2007
Hugo Stephenson, M.D. has been appointed president of iGuard, for Quintiles Transnational Corp., effective immediately. Dr. Stephenson will lead the company's new service that offers personalized safety information and alerts to patients taking presc…
Read More »
August 21, 2007
ImClone Systems, Inc. received approval from the FDA for a second facility to manufacture Erbitux. This new 250,000-sq.-ft. multi-suite manufacturing facility, referred to as "BB50", more than doubles the company's total production capacity…
Read More »
5371 - 5385 of 6609 results
Prev
357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441
Next
